Health Condition 1: N179- Acute kidney failure, unspecified Health Condition 2: K746- Other and unspecified cirrhosis ofliver
Conditions
Interventions
Intervention1: 20 percent Human Albumin: The response of 20 percent human albumin intravenous administration in decompensated cirrhosis patients with Acute Kidney injury Stage greater than IB (S.Creat
Sponsors
Govind Ballabh Pant Institute Of Postgraduate Medical Education And Research
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria Inclusion criteria Diagnosed cases of decompensated cirrhosis with Acute kidney injury stage IB (S.cr greater than or equal to 1/.5mg/dl) Age 18 years to 65 years.
Exclusion criteria
Exclusion criteria: Exclusion criteria CKD on renal replacement therapy (RRT). Post renal transplant Post Liver transplant Hepatocellular carcinoma Known hypersensitivity to human albumin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The response to 20% human albumin as per EASL (European Association for the Study of the Liver) criteria at 24 hours and 48 hoursTimepoint: 24 hours and 48 hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| The survival rate at 28 days and 90 days after AKI (Acute Kidney injury).Timepoint: 28 days and 90 days.;The type and proportion of adverse events with related to human albumin infusion.Timepoint: | — |
Countries
India
Contacts
Public ContactDr Dhruv Bansal
Govind Ballabh Pant Institute of Post Graduate Medical Education and Research
Outcome results
None listed